Compare AQST & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AQST | TATT |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 571.4M |
| IPO Year | 2007 | 2002 |
| Metric | AQST | TATT |
|---|---|---|
| Price | $3.76 | $37.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $9.33 | ★ $61.29 |
| AVG Volume (30 Days) | ★ 2.4M | 125.2K |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $11.13 | $15.09 |
| Revenue Next Year | $40.69 | $11.87 |
| P/E Ratio | ★ N/A | $38.61 |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $30.47 |
| 52 Week High | $6.74 | $64.50 |
| Indicator | AQST | TATT |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 55.85 |
| Support Level | $3.59 | $36.72 |
| Resistance Level | $4.34 | $39.11 |
| Average True Range (ATR) | 0.25 | 1.77 |
| MACD | 0.02 | 0.33 |
| Stochastic Oscillator | 41.85 | 72.81 |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.